Rasagiline
In the US, Rasagiline (rasagiline systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N04BD02
CAS registry number (Chemical Abstracts Service)
0136236-51-6
Chemical Formula
C12-H13-N
Molecular Weight
171
Therapeutic Categories
Treatment of Parkinson's disease
Inhibitor of monoamin oxidase type B (MAO-B)
Chemical Names
(R)-N-2-propynyl-1-indanamine
N-propargyl-1-(R)-aminoindan
Foreign Names
- Rasagilinum (Latin)
- Rasagilin (German)
- Rasagiline (French)
- Rasagilina (Spanish)
Generic Names
- Rasagiline (OS: USAN)
- Rasagiline Mesylate (OS: USAN)
- AGN-1135 (IS)
- Rasagiline methanesulfonate (IS)
- TVP 1012 (IS: Teva)
- TVP-101 (IS)
Brand Names
- Azilect
Lundbeck, Denmark; Lundbeck, Latvia; Lundbeck, Turkey; Teva, Slovakia; Teva Pharmaceuticals, Poland - Parkintreat
Inspire Ph, Egypt - Ralago
KRKA, Slovenia - Rangar
Productos Farmaceuticos Medipharm, Chile - Rasagiline Amneal
Amneal, Netherlands - Rasagiline Aurobindo
Aurobindo, Netherlands - Rasagiline BioOrganics
BioOrganics, Netherlands - Rasagiline CF
Centrafarm, Netherlands - Rasagiline DOC Generici
DOC Generici, Netherlands - Rasagiline Genericon
Genericon, Netherlands - Rasagiline Genthon
Genthon, Netherlands - Rasagiline Krka
Krka, Netherlands - Rasagiline Sandoz
Sandoz, Netherlands - Rasagiline Synthon
Synthon, Netherlands - Rasalin
Vianex, Netherlands - Rasax
AstraZeneca, Argentina - Agilect
Teva, United States - Azilect
Lundbeck, Australia; Lundbeck, Belgium; Lundbeck, Spain; Lundbeck, Finland; Lundbeck, France; Lundbeck, Croatia (Hrvatska); Lundbeck, Ireland; Lundbeck, Sweden; Lundbeck, Thailand; Lundbeck, South Africa; Lundbeck Italia, Italy; Teva, Austria; Teva, Czech Republic; Teva, Greece; Teva, Hungary; Teva, Israel; Teva, Iceland; Teva, Lithuania; Teva, Mexico; Teva, Norway; Teva, Romania; Teva, Serbia; Teva, United States; Teva Canada Innovation, Canada; Teva Pharma, Switzerland; Teva Pharma, Cyprus; Teva Pharma, Germany; Teva Pharma, Portugal; Teva Pharmaceuticals, United Kingdom - Elbrus
Laboratorios Raffo, Chile; Roemmers, Argentina - Menuix
Pharma Investi de Chile, Chile; Roemmers Centroamérica, Guatemala; Roemmers Centroamérica, Honduras; Roemmers Centroamérica, Nicaragua; Roemmers Centroamérica, Panama; Roemmers Centroamérica, El Salvador - Rasagilina Richet
Richet, Argentina - Rasagilin-Mepha
Mepha Pharma, Switzerland
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
